keynote-427 updates: first-line pembrolizumab monotherapy in patients with advanced clear cell r...
Published 3 years ago • 75 plays • Length 2:46Download video MP4
Download video MP3
Similar videos
-
5:04
keynote-427 cohort b: first-line pembrolizumab monotherapy for advanced non-clear cell renal cel...
-
2:25
dr. tykodi on the keynote-427 trial with pembrolizumab in rcc
-
4:20
trial updates in mrcc from asco: keynote-427, resort, e2810 & immotion151
-
1:28
keynote-b61: first-line lenvatinib pembrolizumab in non-clear cell rcc
-
2:18
pembrolizumab monotherapy and pembro-axitinib for rcc
-
6:32
keynote trials show pembrolizumab benefited patients with advanced small cell lung cancer
-
7:13
first-line pembrolizumab plus chemotherapy for patients with advanced squamous nsclc: 3-year fol...
-
2:06
lenvatinib plus pembro for arcc - update on the clear study
-
4:10
non-clear cell kidney cancer trial updates: calypso and keynote-427
-
1:16
dr. tykodi on the clinical implications of the keynote-427 trial in advanced rcc
-
3:30
promising results for axitinib and pembrolizumab in advanced renal cell cancer
-
4:23
first-line therapy options for rcc: lessons from checkmate 214 and keynote-427
-
0:59
combining lenvatinib & pembrolizumab for non-clear cell rcc: keynote-b61 study rationale
-
0:49
clear: lenvatinib and pembrolizumab in advanced renal cell carcinoma
-
5:24
keynote048: first line pembrolizumab for r/m hnscc
-
1:58
dr. rischin on keynote-048 results in head and neck squamous cell carcinoma
-
2:41
leap-011: exploring first-line pembrolizumab lenvatinib for advanced urothelial carcinoma
-
1:45
keynote-426: pembrolizumab and axitinib vs sunitinib in advanced renal cell carcinoma
-
3:03
adjuvant pembrolizumab improves rcc disease-free survival | toni choueiri